The PE Ratio as of September 2024 (TTM) for Chugai Pharmaceutical Co., Ltd. (CHGCY) is 30.74

According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 30.74. This represents a change of 145.32% compared to the average of 12.53 of the last 4 quarters.

Chugai Pharmaceutical Co., Ltd. (CHGCY) Historical PE Ratio (quarterly & annually)

How has CHGCY PE Ratio performed in the past?

The mean historical PE Ratio of Chugai Pharmaceutical Co., Ltd. over the last ten years is 25.53. The current 30.74 PE Ratio has changed 11.94% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's PE Ratio was at its highest in in the December 2017 quarter at 50.69. The PE Ratio was at its lowest in in the December 2022 quarter at 6.67.

Chugai Pharmaceutical Co., Ltd. (CHGCY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chugai Pharmaceutical Co., Ltd. (CHGCY) Average PE Ratio

How has CHGCY PE Ratio performed in the past?

The current PE Ratio of Chugai Pharmaceutical Co., Ltd. (CHGCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Chugai Pharmaceutical Co., Ltd. (CHGCY) PE Ratio vs. Peers

How is CHGCY’s PE Ratio compared to its peers?

Chugai Pharmaceutical Co., Ltd.’s PE Ratio is greater than Scilex Holding Company (-1.02), greater than Merck & Co., Inc. (21.89), greater than Johnson & Johnson (10.52), greater than Pfizer Inc. (-64.86), less than Astellas Pharma Inc. (172.73), greater than Bristol-Myers Squibb Company PFD CONV 2 (-227.93), greater than Otsuka Holdings Co., Ltd. (24.30), less than Novartis AG (0), greater than AstraZeneca PLC (14.58), less than GSK plc (37.83), less than Roche Holding AG (32.58), greater than Bristol-Myers Squibb Company (13.45), greater than Horizon Therapeutics Public Limited Company (-15.41), less than Gilead Sciences, Inc. (88.04), less than Sanofi (99.35), greater than null (16.45),

Build a custom stock screener for Chugai Pharmaceutical Co., Ltd. (CHGCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chugai Pharmaceutical Co., Ltd. (CHGCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.